Dose-effect relationships for DNA-reactive liver carcinogens

Issues in Toxicology

Volumn , Issue , 2012, Pages 33-51

  Williams, G M ^a   Iatropoulos, M J ^a   Jeffrey, A M ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84897550520     PISSN: 17577179     EISSN: 17577187     Source Type: Book Series    
DOI: 10.1039/9781849732925-00033     Document Type: Article

References (88)

1. N. Mantel, The concept of threshold in carcinogenesis, Clin. Pharm. Ther., 1963, 4, 104-109.
2. C. C. Brown, Mathematical aspects of dose-response studies in carcinogenesis - the concept of thresholds, Oncology, 1976, 33, 62-65.
3. F. W. Carlborg, The threshold and the virtually safe dose, Food Chem. Toxicol., 1982, 20, 219-221.
4. W. K. Lutz and A. Kopp-Schneider, Threshold dose response for tumor induction by genotoxic carcinogens modeled via cell-cycle delay, Toxicol. Sci., 1999, 49, 110-115.
5. W. Slob, Thresholds in toxicology and risk assessment, Int. J. Toxicol., 1999, 18, 259-268.
6. J. H. Weisburger and G. M. Williams, Types and amounts of carcinogens as potential human cancer hazards, Cell Biol. Toxicol., 1989, 5, 377-391.
7. G. M. Williams, Mechanistic considerations in cancer risk assessment, Inhalation Toxicol., 1999, 11, 549-554.
8. G. M. Williams, Mechanisms of chemical carcinogenesis and application to human cancer risk assessment, Toxicology, 2001, 166, 3-10.
9. C. Sonich-Mullin, R. Fielder, J. Wiltse, K. Baetke, J. Dempsey, P. Fenner-Crisp, D. Grant, M Hartley, A. Knaap, D. Kroese, I. Mangelsdorf, E. Meek, J. M. Rice and M. Younes, IPCS conceptual framework for evaluating a mode of action for chemical carcininogenesis, Regul. Toxicol. Pharmacol., 2001, 34, 146-152.
10. M. E. Meek, J. R. Bucher, S. M. Cohen, V. DeMarco, R. N. Hill, L. D. Lehman-McKeeman, D. G. Longfellow, T. Pastoor, J. Seed and D. E. Patton, A framework for human relevance analysis of information on carcinogenic modes of action, Crit. Rev. Toxicol., 2003, 33, 591-654.
11. S. Barlow, A. G. Renwick, J. Kleiner, J. W. Bridges, L. Busk, E. Dybing, L. Edler, G. Eisenbrand, J. Fink-Gemmels, A. Knaap, R. Kroes, D. Liem, D. J. G. Müller, S. Page, V. Rolland, J. Schlatter, A. Tritscher, W. Tueting, and G. Würzen, Introduction, in Risk assessment of Substances that are both Genotoxic and Carcinogenic, EFSA/WHO International Conference with support of ILSI Europe, Brussels, 2005, pp. 1-286.
12. G. M. Williams, Application of mode-of-Action considerations in human cancer risk assessment, Toxicol. Lett., 2008, 180, 75-80.
13. J. H. Weisburger and G. M. Williams, Classification of carcinogens as genotoxic and epigenetic as basis for improved toxicologic bioassay methods, in Environmental Mutagens and Carcinogens, ed. T. Sugimura, S. Kondo and H. Takebe, University of Tokyo Press, Tokyo/Alan R. Liss, New York, 1982, pp. 283-294.
14. G. M. Williams, DNA reactive and epigenetic carcinogens, Exp. Toxicol. Pathol., 1992, 44, 457-464.
15. G. M. Williams, E. Karbe, P. Fenner-Crisp, M. J. Iatropoulos and J. H. Weisburger, Risk assessment of carcinogens in food with special consideration of non-genotoxic carcinogens: Scientific arguments for use of risk assessment and for changing the Delaney Clause specifically, Exp. Toxicol. Pathol., 1996, 48, 209-215.
16. E. Dybing, J. Doe, J. Groten, J. Kleiner, J. O'Brien, A. G. Renwick, J. Schlatter, P. Steinberg, A. Tritscher, R. Walker and M. Younes, Hazard characterisation of chemicals in food and diet: dose response, mechanism and extrapolation issues, Food Chem. Toxicol., 2002, 40, 237-282.
17. E. R. Nestmann, D. W. Bryant, C. J. Carr, T. T. Fennell, J. E. Gallagher, N. J. Gorelick, J. A. Swenberg and G. M. Williams, Toxicological significance of DNA adducts: Summary of discussion with an expert panel, Regul. Toxicol. Pharmacol., 1996, 24, 9-18.
18. R. J. Preston and G. M. Williams, DNA-reactive carcinogens: mode of action and human cancer hazard, Crit. Rev. Toxicol., 2005, 35, 673-683.
19. A. M. Jarabek, L. H. Pottenger, L. S. Andrews, D. Casciano, M. R. Embry, J. H. Kim, R. J. Preston, M. V. Reddy, R. Schoeny, D. Shuker, J. Skare, J. Swenberg, G. M. Williams and E. Zeiger, Creating context for the use of DNA adduct data in cancer risk assessment: I. Data organization, Crit. Rev. Toxicol., 2009, 39, 659-678.
20. L. H. Pottenger, N. Carmichael, M. Banton, P. Boogaard, J. Kim, D. Kirkland, R. D. Phillips, J. van Benthem, G.M. Williams and A. Castrovinci, ECETOC workshop on the biological significance of DNA adducts: Follow-up from an expert panel meeting, Mutat. Res., 2009, 678, 152-157.
21. M. Kirsch-Volders, M. Aardema and A. Elhajouji, Concepts of threshold in mutagenesis and carcinogenesis, Mutat. Res., 2000, 464, 3-11.
22. J. A. Swenberg, D. K. La, N. A. Scheller and K. Y. Wu, Dose-response relationships for carcinogens, Toxicol. Lett., 1995, 82-83, 751-756.
23. F. Oesch, M. E. Herrero, J. G. Hengstler, M. Lohmann and M. Arand, Metabolic detoxification: Implications for thresholds, Toxicol. Pathol., 2000, 28, 382-387.
24. G. M. Williams, M. J. Iatropoulos and A.M. Jeffrey, Mechanistic basis for nonlinearities and thresholds in rat liver carcinogenesis by the DNAreactive carcinogens 2-Acetylaminofluorene and diethylnitrosamine, Toxicol. Pathol., 2000, 28, 388-395.
25. J. H. Hengstler, M. S. Bogdanffy, H. M. Bolt and F. Oesch, Challenging dogma: Thresholds for genotoxic carcinogens? The case of vinyl acetate, Annu. Rev. Pharmacol. Toxicol., 2003, 43, 485-520.
26. J. H. Farmer, R. L. Kodell, D. L. Greenman and G. W. Shaw, Dose and time responses models for the incidence of bladder and liver neoplasms in mice fed 2-Acetylamino-fluorene continuously, J. Environ. Pathol. Toxicol., 1980, 3, 55-68.
27. A. Maekawa, T. Ogiu, C. Matsuoka, H. Onodera, K. Furuta, Y. Kurokawa, M. Takahashi, T. Kokubo, H. Tanigawa and Y. Hayashi, Carcinogenicity of low doses of N-ethyl-N-nitrosourea in F344 rats: A dose-response study, GANN, 1984, 75, 117-125.
28. W. Lijinsky, R. M. Kovatch, C. W. Riggs and P. T. Walters, Dose-response study with N-nitrosomorpholine in drinking water of F-344 rats, Cancer Res., 1988, 48, 2089-2095.
29. A. Maekawa, H. Onodera, Y. Matsushima, T. Nagaoka, A. Todate, M. Shibutani, Y. Kodama and Y. Hayashi, Dose-response carcinogenicity in rats on low-dose levels of N-ethyl-N-nitrosourethane, Jpn. J. Cancer Res., 1989, 80, 632-636.
30. R. Peto, R. Gray, P. Brantom and P. Grasso, Effects on 4080 rats of chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine: A detailed dose-response study, Cancer Res., 1991, 51, 6415-6451.
31. R. Peto, R. Gray, P. Brantom and P. Grasso, Dose and time relationships for tumor induction in the liver and esophagus of 4080 inbred rats by chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine, Cancer Res., 1991, 51, 6452-6469.
32. G. S. Bailey, A. P. Reddy, C. B. Pereira, V. Harttig, W. Baird, J. M. Spitzbergen, J. D. Hendrinks, G. A. Orner, D. E. Williams and J. A. Swenberg, Nonlinear cancer response of ultralow dose: A 40,800-Animal ED001 tumor and biomarker study, Chem. Res. Toxicol., 2009, 22, 1264-1276.
33. W. J. Waddell, Thresholds in chemical carcinogenesis: what are animal experiments telling us? Toxicol. Pathol., 2003, 31, 260-262.
34. G. M. Williams, Functional markers and growth behavior of preneoplastic hepatocytes, Cancer Res., 1976, 36, 2540-2543.
35. P. Bannasch, Preneoplastic lesions as end points in carcinogenicity testing. I. Hepatic preneoplasia, Carcinogenesis, 1986, 7, 689-695.
36. G. M. Williams, Chemically induced rodent preneoplastic lesions as indicators of carcinogenic activity, in The Use of Short- and Medium-term Tests for Carcinogens and Data on Genetic Effects in Carcino genic Hazard Evaluation, ed. D. B. McGregor, J.M. Rice and S. Venitt, IARC Scientific Publications No. 146, International Agency for Research on Cancer, Lyon, 1999, pp. 185-202.
37. G. M. Williams, The significance of chemically-induced hepatocellular altered foci in rat liver and application to carcinogen detection, Toxicol. Pathol., 1989, 17, 663-674.
38. H. Tsuda, S. Fukushima, H. Wanibuchi, K. Morimura, D. Nakae, K. Imaida, M. Tatematsu, M. Hirose, K. Wakabayashi and M. A. Moore, Value of GST-P positive preneoplastic hepatic foci in dose-response studies of hepatocarcinogenesis: evidence for practical thresholds with both genotoxic and nongenotoxic carcinogens. A review of recent work, Toxicol. Pathol., 2003, 31, 80-86.
39. G. M. Williams, M. J. Iatropoulos, C. X. Wang, N. Ali, A. Rivenson, L. A. Peterson, C. Schulz and R. Gebhardt, Diethylnitrosamine exposureresponses for DNA damage, centrilobular cytotoxicity, cell proliferation and carcinogenesis in rat liver exhibit some non-linearities, Carcinogenesis, 1996, 17, 2253-2258.
40. G. M. Williams, M. J. Iatropoulos, C. X. Wang, A. M. Jeffrey, S. Thompson, B. Pittman, M. Palasch and R. Gebhardt, Non-linearities in 2-Acetylaminofluorene exposure-responses for genotoxic and epigenetic effects leading to initiation of carcinogenesis in rat liver, Toxicol. Sci., 1998, 45, 152-161.
41. G. M. Williams, M. J. Iatropoulos, A. M. Jeffrey, F. Q. Luo, C. X. Wang, S. Thompson and B. Pittman, Diethylnitrosamine exposure-responses for DNA ethylation, hepatocellular proliferation and initiation of carcinogenesis in rat liver display non-linearities and thresholds, Arch. Toxicol., 1999, 73, 394-402.
42. G. M. Williams, M. J. Iatropoulos and A. M. Jeffrey, Thresholds for the effects of 2-Acetylaminofluorene in rat liver, Toxicol. Pathol., 2004, 32(Suppl. 2), 85-91.
43. G. M. Williams, M. J. Iatropoulos and A. M. Jeffrey, Thresholds for DNAreactive (genotoxic) organic carcinogens, J. Toxicol. Pathol., 2005, 18, 69-77.
44. O. Hino and T. Kitagawa, Existence of a practical threshold dose for the hepatocarcinogen 30-methyl-4-(dimethylamino) azobenzene in rat liver, GANN, 1981, 72, 637-638.
45. E. J. Calabrese, Hormesis is central to toxicology, pharmacology and risk assessment, Hum. Exper. Toxicol., 2010, 29, 249-261.
46. K. K. Rozman and J. Doull, Scientific foundations of hormesis. Part 2. Maturation, strengths, limitations, and possible applications in toxicology, pharmacology, and epidemiology, Crit. Rev. Toxicol., 2003, 33, 451-462.
47. K. K. Rozman, Hormesis and risk assessment, Human Exp. Toxicol., 2005, 24, 255-257.
48. M. Root, T. Lange and T. C. Campbell, Dissimilarity in aflatoxin dose-response relationships between DNA adduct formation and development of preneoplastic foci in rat liver, Chem. Biol. Interact., 1997, 106, 213-227.
49. H. Enzmann, H. Zerban, A. Kopp-Schneider, E. Loser and P. Bannach, Effects of low doses of N-nitrosomorpholine on the development of early stages of hepatocarcinogenesis, Carcinogenesis, 1995, 16, 1513-1518.
50. S. Fukushima, Low-dose carcinogenicity of a heterocyclic amine, 2-Amino-3, 8-dimethylimidazo[4, 5-f]quinoxaline: Relevance to risk assessment, Cancer Lett., 1999, 143, 157-159.
51. S. Fukushima, H. Wanibuchi, K. Morimura, M. Wei, D. Nakae, Y. Konishi, H. Tsuda, N. Uehara, K. Imaida, T. Shirai, M. Tatematsu, T. Tsukamoto, M. Hirose, F. Furukawa, K. Wakabayashi and Y. Totsuka, Lack of a dose-response relationship for carcinogenicity in the rat liver with low doses of 2-Amino-3, 8-dimethylimidazo[4, 5-f]quinoxaline or N-nitrosodiethylamine, Jpn. J. Cancer Res., 2002, 93, 1076-1082.
52. International Agency for Research on Cancer (IARC), Some Naturally Occurring Substances: Food Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 56, IARC, Lyon, 1993.
53. T. Murai, S. Mori, J. S. Kang, K. Morimura, H. Wanibuchi, Y. Totsuka and S. Fukushima, Evidence of a threshold-effect for 2-Amino-3, 8-dimethylimidazo[4, 5-f]quinoxaline liver carcinogenicity in F344/DuCrj rats, Toxicol Pathol., 2008, 36, 472-477.
54. R. J. Laib, T. Pellio, V. M. Wünschel, N. Zimmermann and H. M. Bolt, The rat liver foci bioassay: II. Investigations on the dose-dependent induction of ATPase-deficient foci by vinyl chloride at very low doses, Carcinogenesis, 1985, 6, 69-72.
55. G. M. Williams, R. Gebhardt, H. Sirma and F. Stenbäck, Non-linearity of neoplastic conversion induced in rat liver by low exposures to diethylnitrosamine, Carcinogenesis, 1993, 14, 2149-2156.
56. G. M. Williams, Chemicals with carcinogenic activity in rodent liver, in ComprehensiveToxicology, Academic Press, Oxford, 2010, Vol. 9, pp. 221-250.
57. G. M. Williams and K. Watanabe, Quantitative kinetics of development of N-2-fluroenylacetanide-induced altered (hyperplastic) hepatocellular foci resistant to iron accumulation and of their reversion or persistence following removal of carcinogen, J. Natl. Cancer Inst., 1978, 61, 113-121.
58. D. J. Loury, T. L. Goldsworthy and B. E. Butterworth, The value of measuring cell replication as a predictive index of tissue-specific tumorigenic potential, in Nongenotoxic Mechanisms in Carcinogenesis, ed. B. E. Butterworth and T. J. Slaga, The Banbury Report, Cold Spring Harbor Laboratory, NY, 1987, pp. 119-136.
59. S. M. Cohen and L. B. Ellwein, Genetic errors, cell proliferation, and carcinogenesis, Cancer Res., 1991, 51, 6493-6505.
60. G. M. Williams and M. J. Iatropoulos, Alteration of liver cell function and proliferation: differentiation between adaptation and toxicity, Toxicol. Pathol., 2002, 30, 41-53.
61. C. Biémont, A brief history of the status of transposable elements: From junk DNA to major players in evolution, Genetics, 2010, 186, 1085-1093.
62. T. Lindahl, Instability and decay of the primary structure of DNA, Nature, 1993, 362, 709-715.
63. L. J. Marnett and P. C. Burcham, Endogenous DNA adducts: Potential and paradox, Chem. Res. Toxicol., 1993, 6, 771-785.
64. A. C. Povey, DNA adducts: endogenous and induced, Toxicol. Pathol., 2000, 28, 405-414.
65. H. Druckrey, D. Steinhoff, R. Preussmann and S. Ivankovic, Induction of cancer by a single dose of methylnitrosourea and various dialkylnitrosamines in rats, Z. Krebsforsch., 1964, 66, 1-10.
66. H. C. Pitot, L. Barsness, T. Goldworthy and T. Kitagawa, Biochemical characterization of stages of hepatocarcinogenesis after a single dose of diethylnitrosamine, Nature, 1978, 271, 456-458.
67. T. Tanaka, H. Mori, N. Hirota, K. Furuya and G. M. Williams, Effect of DNA synthesis on induction of preneoplastic and neoplastic lesions in rat liver by a single dose of methoxyazoxymethanol acetate, Chem.-Biol. Interact., 1986, 58, 13-27.
68. G. M. Williams, M. J. Iatropoulos, M. V. Djordjevic and O. P. Kaltenberg, The triphenylethylene drug, tamoxifen is a strong liver carcinogen in the rat, Carcinogenesis, 1993, 14, 315-317.
69. International Agency for Research on Cancer (IARC), Evaluation of Carcinogenic Risks to Humans: Some Pharmaceutical Drugs, Tamoxifen, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 66, IARC, Lyon, 1996, pp. 367-388.
70. H. Glatt, W. Davis, W. Meinl, H. Hermersdörfer, S. Venitt and D. H. Phillips, Rat, but not human, sulfotransferase activates a tamoxifen metabolite to produce DNA adducts and gene mutations in bacteria and mammalian cells in culture, Carcinogenesis, 1998, 19, 1709-1713.
71. G. M. Williams, B. Reiss and J. H. Weisburger, A comparison of the animal and human carcinogenicity of several environmental, occupational and therapeutic chemicals, in Mechanisms and Toxicology of Chemical Carcinogens and Mutagens, ed. G. Flamm and R. Lorentzen, Princeton Scientific Publishers, Princeton, NJ, 1985, Vol. IX, pp. 207-248.
72. International Agency for Researchon Cancer (IARC), Agents classifiedby the IARC Monographs, Volumes 1-102, IARC, Lyon, France, 2011. http://monographs.iarc.fr/ENG/Classification/ClassificationsGroupOrder.pdf [accessed January 2012].
73. D. E. Williams, G. Orner, K. D. Willard, S. Tilton, J. D. Hendricks, C. Pereira, A. D. Benninghoff and G. S. Bailey, Rainbow trout (oncorhynchus mykiss) and ultra-low dose cancer studies, Comp. Biochem. Physiol. Toxicol. Pharmacol., 2009, 149, 175-181.
74. D. Schmähl, Combination effects in chemical carcinogenesis, Arch. Toxicol. Suppl., 1980, 4, 29-40.
75. G. M. Williams, Interactive carcinogenesis in the liver, in Falk Symposium: Liver Cell Carcinoma, ed. P. Bannasch, D. Keppler and G. Weber, Academic Press, Boston, 1989, Vol. 51, pp. 197-216.
76. G. M. Williams, S. Katayama and T. Ohmori, Enhancement of hepatocarcinogenesis by sequential administration of chemicals: summation versus promotion effects, Carcinogenesis, 1981, 2, 1111-1117.
77. G. M. Williams and K. Furuya, Distinction between liver neoplasm promoting and syncarcinogenic effects demonstrated by exposure to phenobarbital or diethylnitrosamine either before or after N-2-fluorenylacetamide, Carcinogenesis, 1984, 5, 171-174.
78. K. Mayura, P. Parker, W. O. Berndt and T. D. Philips, Effect of simultaneous prenatal exposure to ochratoxin A and citrinin in the rat, J. Toxicol. Environ. Health, 1984, 13, 553-561.
79. B. L. Van Duren and B. M. Goldschmidt, Carcinogenic and tumorpromoting agents in tobacco carcinogenesis, J. Natl. Cancer Inst., 1976, 56, 1237-1242.
80. J. DiGiovanni, J. Rymer, T. J. Slaga and R.K. Boutwell, Anticarcinogenis and cocarcinogenic effects of benzo[e]pyrene and dibenz[a, c]anthracene on skin tumor initiation by polycyclic hydrocarbons, Carcinogenesis, 1982, 3, 371-375.
81. T. A. Smolarek, W. M. Baird, E. P. Fisher and J. DiGiovanni, Benzo(e)-pyrene-induced alterations in the binding of benzo(a)pyrene and 7, 12-dimethylbenz(a)anthracene to DNA in Sencar mouse epidermis, Cancer Res., 1987, 47, 3701-3706.
82. J. E. Rice, T. J. Hosted and E. J. Lavoie, Fluoranthene and pyrene enhance benzo[a]pyrene-DNA adduct formation in vivo in mouse skin, Cancer Lett., 1984, 24, 327-333.
83. G. M. Williams, Food-borne carcinogens, Prog. Clin. Biol. Res., 1986, 206, 73-81.
84. International Agency for Research on Cancer (IARC), Some Traditional Herbal Medicines, some Mycotoxins, Naphthalene and Styrene, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 82, IARC, Lyon, 2002, pp. 169-275.
85. M. Koivusalo and T. Vartiainen, Drinking water chlorination by-products and cancer, Rev. Environ. Health., 1997, 12, 81-90.
86. J. M. M. Meijers, G. M. H. Swaen and L. J. N. Bloemen, The predictive value of animal data in human cancer risk assessment, Regul. Toxicol. Pharmacol., 1997, 25, 94-102.
87. S. Felter, R. Conolly, J. Bercu, P. Bolger, A. Boobis, P. Bos, P. Carthew, N. Doerrer, J. Goodman, W. Harrouk, D. Kirkland, S. Lau, G. Llewellyn, R. Preston, R. Schoeny, A. Schnatter, A. Tritscher, F. van Velsen and G. M. Williams, A proposed framework for assessing risk from less-than lifetime exposures to carcinogens, Crit. Rev. Toxicol., 2011, 41, 507-544.
88. G. M. Williams, T. Tanaka, H. Maruyama, Y. Maeura, J. H. Weisburger and E. Zang, Modulation by butylated hydroxytoluene of liver and bladder carcinogenesis induced by chronic low level exposure to 2-Acetylaminofluorene, Cancer Res., 1991, 51, 6224-6230.